2011 ASH Program Book - American Society of Hypertension

More documents

Recommendations

Info

Faculty Disclosure Listing continued Daniel Levy, MD Member, ASH Board of Directors. Nita A. Lindi, PharmD, PhD, MSPH I have no relationships to disclose. Tianh Liu, MD Employment Income/Salary: Pi County People’s Hospital. Charles J. Lowenstein, MD I have no relationships to disclose. Jianfang Luo, MD I have no relationships to disclose. James M. Luther, MD I have no relationships to disclose. Giuseppe Mancia, MD Advisor/Consultant: Bayer, Boehringer-Ingelheim, MSD, Menaribni International, Novartis, Recordati, Sanofi-Aventis, Servier. Grant/ Research Support: Gilead, Servier. Samuel J. Mann, MD Grant/Research Support: Forest. Speaker’s Bureau/Speaking/Teaching: Forest. Athanasios J. Manolis, MD, PhD Advisor/Consultant: Menarini, Abbott. Speakers’ Bureau/Speaking/ Teaching: Menarini, Recordati. Allyn L. Mark, MD I have no relationships to disclose. Barry J. Materson, MD, MBA Grant/Research Support: Forest, Takeda, Merck. David L. Mattson, PhD I have no relationships to disclose. Richard J. McManus, MD Grant/Research Support: Omron Europe (potential). John Merenich, MD I have no relationships to disclose. Franz H. Messerli, MD Advisor/Consultant: Novartis, Daiichi-Sankyo, Sanofi-Aventis, Takeda, Abbott. Grant/Research Support: Forest, Daiichi-Sankyo, Boehringer-Ingelheim. Treasurer, ASH Board of Directors. Nancy Houston Miller, RN, BSN Advisor/Consultant: Abbott, Gilead, Novartis. Mark E. Molitch, MD Advisor/Consultant: Novartis, Abbott. Grant/Research Support: Eli Lily. Krzysztof Narkiewicz, MD, PhD Speakers’ Bureau/Speaking/Teaching: Berlin Chernie Menarini, Boehringer-Ingelheim, Daiichi-Sankyo, Krka, Novartis, Servier. 150
Faculty Disclosure Listing continued L. Gabriel Navar, PhD Advisor/Consultant: Forest, Novartis, Nicor, Merck & Co., Boehringer-Ingelheim. Trustee/Board Member/Committee Member: American Heart Association, American Society of Hypertension, InterAmerican Society of Hypertension. Grant/Research Support: National Heart, Lung and Blood Institute, NCRR, Merck, Forest. Ownership Interest (Stocks, Excluding Diversified Mutual Funds): Abbott, AstraZeneca, Baxter International, Merck & Co., Pfizer, Inc. Speakers’ Bureua/ Speaking/Teaching: Merck & Co., Forest Pharmaceuticals. Shawna D. Nesbitt, MD, MS Advisor/Consultant: Daiichi-Sankyo. Speakers’ Bureau/Speaking/ Teaching: Novartis, Gilead, Boehringer-Ingelheim. Joel M. Neutel, MD Speakers’ Bureau/Speaking/Teaching: Novartis, Forest, Bristol-Myers Squibb – Sanofi-Aventis, Takeda, Boehringer-Ingelheim, Daiichi- Sankyo. Susanne B. Nicholas, MD, PhD, MPH I have no relationships to disclose. Eoin O’Brien, MD I have no relationships to disclose. Gbenga Ogedegbe, MD, MPH, MS I have no relationships to disclose. Suzanne Oparil, MD Advisor/Consultant: Boehringer-Ingelheim, Daiichi-Sankyo, Eli Lily, Forest, NiCox, Novartis, Omron. Grant/Research Support: Amgen, Inc., Merck & Co. Speakers’ Bureau/Speaking/Teaching: Daiichi- Sankyo, Novartis, Pfizer. Julio A. Panza, MD I have no relationships to disclose. Vasilios Papademetriou, MD I have no relationships to disclose. Thomas A. Pearson, MD, PhD, MPH I have no relationships to disclose. Aldo J. Peixoto, MD I have no relationships to disclose. Robert A. Phillips, MD, PhD Member, ASH Board of Directors. F. Xavier Pi‐Sunyer, MD, MPH Advisor/Consultant: Novo Nordisk, AstraZeneca. Grant/Research Support: Novo Nordisk. Bertram Pitt, MD Advisor/Consultant: Relypsa. Ownership Interest (Stocks, Excluding Diversified Mutual Funds): Relypsa, BG-Medicine, Nile Therapeutics. Velvie A. Pogue, MD Employment Income/Salary: Columbia University Affiliation at the Harlem Hospital Center. Grant/Research Support: Amgen. David M. Pollock, PhD Advisor/Consultant: Abbott Laboratories. Howard J. Pratt, MD Grant/Research Support: National Institutes of Health. 151
Page 1 and 2:
American Society of Hypertension, I
Page 3:
Visit booth #1100 to find out more
Page 6 and 7:
Past Presidents of the American Soc
Page 8 and 9:
Program Color Key The pages of this
Page 10 and 11:
Letter continued Following the Awar
Page 12 and 13:
General Information continued Discl
Page 14 and 15:
General Information continued ASH S
Page 16 and 17:
General Information continued ASH P
Page 18 and 19:
2011 ASH Corporate Members Boehring
Page 20 and 21:
ASH Leadership 2010-2011 Board of D
Page 22 and 23:
Special Lecture Monday, May 23, 201
Page 24 and 25:
Young Scholar Award* Monday, May 23
Page 26 and 27:
Special Lecture Monday, May 23, 201
Page 28 and 29:
2011 Abstract Reviewers Lawrence J.
Page 30 and 31:
More than half of hypertensive pati
Page 32 and 33:
Poster Category Presentation Poster
Page 34 and 35:
2011 ASH Faculty Rajiv Agarwal, MD
Page 36 and 37:
2011 ASH Faculty continued David L.
Page 38 and 39:
American Society of Hypertension, I
Page 40 and 41:
Program Color Key The pages of this
Page 42 and 43:
MAY 21 Saturday Morning Hypertensio
Page 44 and 45:
MAY 21 Sessions Saturday Afternoon
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
MAY 21 Posters Saturday Evening Pos
Page 52 and 53:
MAY 22 Sunday morning Sessions cont
Page 54 and 55:
MAY 22 Sessions Sunday Morning 9:00
Page 56 and 57:
MAY 22 Sessions Sunday Morning 9:00
Page 58 and 59:
MAY 22 Debates Sunday Morning 11:00
Page 60 and 61:
MAY 22 Plenary Session I Sunday Aft
Page 62 and 63:
MAY 22 Special Sessions Sunday Afte
Page 64 and 65:
MAY 22 Sessions Sunday Afternoon 3:
Page 66 and 67:
MAY 23 Satellite Symposium 6:00 AM
Page 68 and 69:
MAY 23 Sessions Monday morning 8:00
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
MAY 23 Plenary Session II Monday Af
Page 80 and 81:
MAY 24 Sessions Tuesday Morning 8:1
Page 82 and 83:
MAY 24 Sessions Tuesday Morning 10:
Page 84 and 85:
MAY 24 Sessions Tuesday Morning 10:
Page 87 and 88:
2011 American Society of Hypertensi
Page 89 and 90:
Saturday Afternoon MAY 21 Posters 4
Page 91 and 92:
Saturday Afternoon MAY 21 Posters P
Page 93 and 94:
Saturday Afternoon MAY 21 Posters E
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Saturday Afternoon MAY 21 Posters I
Page 101 and 102: Saturday Afternoon MAY 21 Posters P
Page 107 and 108: Sunday Morning MAY 22 Posters 10:00
Page 109 and 110: Sunday Morning MAY 22 Posters 10:00
Page 111 and 112: Sunday Morning MAY 22 Posters PO-13
Page 127 and 128: Monday Morning Afternoon MAY 21 23
Page 147 and 148: Faculty Disclosure Listing Rajiv Ag
Page 149 and 150: Faculty Disclosure Listing continue
Page 151: Faculty Disclosure Listing continue
Page 155 and 156: Faculty Disclosure Listing continue
Page 157 and 158: ASH Hypertension Resource Pavilion
Page 159 and 160: 2011 ASH Innovations Theater Rhinel
Page 161 and 162: 2011 ASH Exhibitors continued A & D
Page 163 and 164: 2011 ASH Exhibitors continued David
Page 165 and 166: 2011 ASH Exhibitors continued Inter
Page 167 and 168: 2011 ASH Exhibitors continued Novar
Page 169 and 170: 2011 ASH Exhibitors continued Wiley
Page 171 and 172: Author Index Berezina, Aelita V., 8
Page 173 and 174: Author Index Eguchi, Kazuo, 110, 13
Page 175 and 176: Author Index Ikeda, Yasuhiro, 116 I
Page 177 and 178: Author Index Makani, Harikrishna, 1
Page 179 and 180: Author Index Rabelink, Ton J., 93 R
Page 181 and 182: Author Index Tatsis, I., 92, 124 Ta
Page 183 and 184: Hilton New York Floor Plans Second
Page 185 and 186: Hilton New York Floor Plans Fourth
Page 187 and 188: Tekamlo (aliskiren and amlodipine)
Page 189 and 190: 25% (systolic) and 27% (diastolic)
Page 191 and 192: Two cases of angioedema with respir
Page 193 and 194: amlodipine and sildenafil were used
Page 195 and 196: Amlodipine besylate Single oral dos
show all

2011 ASH Program Book - American Society of Hypertension

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?